Dr. Vladimir Cmiljanovic

Dr. Vladimir Cmiljanovic is a highly accomplished individual with a strong background in chemistry. As the founder, chairman, and CEO of various biotech companies such as Swiss Rockets AG, Rocketvax AG, Torqur AG, Torpedo Pharmaceuticals AG, PIQUR Therapeutics AG, and TargImmune Therapeutics AG, Dr. Cmiljanovic has been instrumental in developing innovative medical solutions for cancer treatment and infectious diseases. With a Bachelor of Science in Chemistry, a Master of Science in Chemistry, a Ph.D. in Medicinal Chemistry, and a Postdoc in Medicinal and Pharmaceutical Chemistry from reputable institutions like the University of Basel and University of Kragujevac, Dr. Vladimir has the expertise and knowledge to lead these groundbreaking ventures in the field of biopharmaceuticals.